|
CN103450083A
|
|
Geldanamycin derivatives and preparation method and applications thereof
|
|
CN103588723A
|
|
Preparation method for novel febuxostat crystal form A
|
|
CN103588724A
|
|
Febuxostat crystal form A and preparation method thereof
|
|
CN104370846A
|
|
Method for preparing linezolid IV crystal form
|
|
CN103420953A
|
|
Method for purifying orlistat intermediate
|
|
CN104109179A
|
|
C-aryl glucoside derivatives, preparation method and application thereof
|
|
CN103142512A
|
|
High-quality composition containing oxaliplatin and preparation method of composition
|
|
CN103142511A
|
|
High-purity and high-stability composition containing oxaliplatin and preparation method of composition
|
|
CN103087928A
|
|
Fungus Glarea lozoyensis and application thereof for controlling microbial metabolite Pneumocandin Kangding B0
|
|
CN102860991A
|
|
Medicine composition containing febuxostat and preparation method thereof
|
|
CN103450164A
|
|
Geldanamycin derivatives as well as preparation methods and uses thereof
|
|
CN102688196A
|
|
Omeprazole pellets and preparation method thereof
|
|
CN102675426A
|
|
Extraction and purification method of daptomycin
|
|
CN102643245A
|
|
Linezolid crystal form and preparation method thereof
|
|
CN102552168A
|
|
Pharmaceutical composition containing orlistat and its preparation method
|
|
CN102559813A
|
|
Low-impurity acarbose and preparation method thereof
|
|
CN102512957A
|
|
Concentrating device and concentrating method of acarbose destaining solution
|
|
CN102319245A
|
|
Composition containing repaglinide and metformin hydrochloride and preparation thereof
|
|
CN102240291A
|
|
Imatinib-containing composition and preparation method thereof
|
|
CN102603635A
|
|
Derivatives of geldanamycin, as well as preparation method and application thereof
|
